Inari Medical Inc. (Nasdaq: NARI)

https://www.inarimedical.com

Inari Medical, Inc. is a privately held venture backed medical device company dedicated to the development of innovative catheter-based technologies for the treatment of venous thromboembolism ("VTE"). Inari is focused on solutions that enable the safe removal of large clot volumes from big vessels without the use of thrombolytic drugs. Inari has developed two novel mechanical thrombectomy technology platforms, the FlowTriever and ClotTriever Systems. Both Systems are 510(k) cleared by the U.S. FDA for thrombectomy in the peripheral vessels and have also received the CE mark. Inari was founded in 2013 as a spin-out of Inceptus Medical, a medical device incubator. The company is backed by Gilde Healthcare, Versant Ventures, U.S. Venture Partners, the founders, and other private investors. *

	Start	2013-01-01 established (s-off)
	Group	Inari Medical (Group)
	Industry	medical device
	Industry 2	FlowTriever system
	Person	Hykes, Drew (Inari Medical 202311 CEO)
	Person 2	Hoffman, Bill (Inari Medical 201803 CEO)

	Region	Irvine, CA
	Country	United States (USA)
	Street	6001 Oak Canyon Suite 100
	City	92618 Irvine, CA
	Tel	+1-949-600-8433
		Address record changed: 2023-11-04

Basic data	Employees	n. a.
	Currency	USD
	Annual sales	383,500,000 (revenue, annual (2022) 2022-12-31)

		* Document for »About Section«:

		Record changed: 2023-11-04